Novozymes A/S

Novozymes A/S

World Rank (Jan-05-2024)
1,197
Market Cap (Jan-05-2024)
14.692 Billion USD
World Rank (Jul-30-2023)
1,283
Market Cap (Jul-30-2023)
13.844 Billion USD
World Rank (Jan-07-2022)
959
Market Cap (Jan-07-2022)
21.906 Billion USD
World Rank (Jan-01-2021)
1,124
Market Cap (Jan-01-2021)
15.999 Billion USD
Headquarters Country
Denmark
CEO
Ester Baiget
Chairman
Jorgen Buhl Rasmussen
Employee Count
6,700
Employee Count as of Date
As on December-2022
World Region
Europe
World Subregion
Northern Europe
Annual Revenue in USD
2,595 Million USD
Annual Operating Income in USD
655 Million USD
Annual Net Income in USD
543 Million USD
Annual Results for Period Ending
Dec-2022 ending year
Total Assets in USD
4,136 Million USD
Total Liabilities in USD
2,033 Million USD
Total Equity in USD
2,103 Million USD
Balance Sheet for Period Ending
Dec-2022 ending year
Business Sector
Healthcare
Biotechnology
Biopharmaceutical
Basic Materials
Chemicals
Company Website
NOVOZYMES A/S
Wikipedia
Wikipedia
Yahoo
Yahoo @ Copenhagen
Company Profile

Novozymes is a Biotechnology and Pharmaceutical company with headquarters is in Denmark.

Facts About Company

For year ending Dec-2022, Novozymes annual revenue was 17,553 million DKK and EBITDA was 6,046 million DKK and net profit was 3,686 million DKK.

As on December-2022, Novozymes had 6,700 employees.

Founded Year
2000
Stock Category
S&P EUROPE 350
Stock Exchange
Nasdaq Nordic
Copenhagen
Company SubCategory
Top Healthcare Companies in Europe

Share